IFNG and melanoma: The analysis of gene expression profiles of melanoma patients with checkpoint inhibitor treatment detected IFNγ-related mRNA profiles, which predicted clinical response to PD-1 treatment, underlining the huge clinical benefit of transcriptome sequencing studies (Ayers et al., 2017).